Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Karyopharm Therapeutics (KPTI) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.14 B
According to Karyopharm Therapeutics
's latest financial reports the company has -$0.14 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Karyopharm Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.14 B | 717.76% |
| 2022-12-31 | $-16.66 M | -79.09% |
| 2021-12-31 | $-79.68 M | -257.62% |
| 2020-12-31 | $50.54 M | 1.55% |
| 2019-12-31 | $49.77 M | -72.83% |
| 2018-12-31 | $0.18 B | 41.48% |
| 2017-12-31 | $0.12 B | -20.2% |
| 2016-12-31 | $0.16 B | -18.21% |
| 2015-12-31 | $0.19 B | -4.08% |
| 2014-12-31 | $0.20 B | 33.47% |
| 2013-12-31 | $0.15 B | -655.78% |
| 2012-12-31 | $-27.88 M | 120.35% |
| 2011-12-31 | $-12.66 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $38.82 B | -28,606.09% | 🇺🇸 USA |
 Merck MRK | $37.63 B | -27,730.94% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | -12,249.24% | 🇺🇸 USA |
 Exelixis EXEL | $2.26 B | -1,762.12% | 🇺🇸 USA |